Buprenorphinum, Naloxonum
| Medicinal product name | Bupensanduo 2 mg/0.5 mg sublingual tablets |
|---|---|
| Pharmaceutical form | Sublingual tablet |
| Strength | 2 mg/0.5 mg |
| Information from the MAH on shortages | No information on expected shortages |
| Legal status | Prescription (Pr.I, Pr.II nark.) |
| Package leaflet |  20-04-2023
|
| Summary of product characteristics | 20-04-2023
|
| ATC code | N07BC51 – Other nervous system drugs |
| Information for Marketing authorisation holders | View |
Medicinal products (8)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N7 (2 mg/0,5 mg) |
OPA/Al/PVC/Al blister | € 20.36 | 18-0090-01 |
Labelling text Apr 20, 2023 Labelling text Apr 20, 2023 |
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N28 (2 mg/0,5 mg) |
OPA/Al/PVC/Al blister | 18-0090-02 |
Labelling text Apr 20, 2023 Labelling text Apr 20, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N49 (2 mg/0,5 mg) |
OPA/Al/PVC/Al blister | 18-0090-03 |
Labelling text Apr 20, 2023 Labelling text Apr 20, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N56 (2 mg/0,5 mg) |
OPA/Al/PVC/Al blister | 18-0090-04 |
Labelling text Apr 20, 2023 Labelling text Apr 20, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N28: 28 × 1 (2 mg/0,5 mg) |
OPA/Al/PVC/Al unit-dose blister | 18-0090-05 |
Labelling text Apr 20, 2023 Labelling text Apr 20, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N7: 7 × 1 (2 mg/0,5 mg) |
OPA/Al/PVC/Al unit-dose blister | 18-0090-06 |
Labelling text Apr 20, 2023 Labelling text Apr 20, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N49: 49 × 1 (2 mg/0,5 mg) |
OPA/Al/PVC/Al unit-dose blister | 18-0090-07 |
Labelling text Apr 20, 2023 Labelling text Apr 20, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N56: 56 × 1 (2 mg/0,5 mg) |
OPA/Al/PVC/Al unit-dose blister | 18-0090-08 |
Labelling text Apr 20, 2023 Labelling text Apr 20, 2023 |
Registration information
| Marketing authorisation No. | 18-0090 |
|---|---|
| Date of authorisation | Jun 5, 2018 |
| Marketing authorisation holder, country | G.L. Pharma GmbH, Austria |
